creates problematic risk factors and necessitates unconventional solutions. In its 2014 policy statement regarding off-label medication use in children, the American Academy of Pediatrics (AAP) asserted that federal…
down-regulates PIBF. Because mifepristone is an abortafacient, most governmental agencies have restricted its off-label use. Compassionate use INDâÂ?Â?s granted by the FDA has allowed mifepristone treatment…
approved for moderate-to-severe atopic dermatitis requiring systemic treatment. It was expanded to off-label treatment of numerous dermatological conditions. We provide an update on the increasing scope ... dermatitis”…
Objective: The research aims to present the off-label use of drugs in pediatrics. Methods: A systematic review of the databases: LILACS, SciELO, MEDLINE and BVS, with keywords in Portuguese ... items to compose the…
context, we developed a new network-based algorithm for drug repurposing called SAveRUNNER (Searching off-lAbel dRUg aNd NEtwoRk), with the aim to offer a promising framework to efficiently detect ... diseases located…
Methods: In a case-control study, 109 CHF patients, 54 were given adjunctive off-label RAN added to ACC/AHA Guideline therapy (RANCHF). MACE and SB were compared with ... adults with triggered premature ventricular…
Methods: In a case-control study, 109 CHF patients, 54 were given adjunctive off-label RAN added to ACC/AHA Guideline therapy (RANCHF). MACE and SB were compared with ... adults with triggered premature ventricular…
neuropathic pain, and anxiety disorders. In opioid users, pregabalin is increasingly being self-administered off-label due to its euphoria effect at high doses. We investigated the effects of pregabalin ... withdrawal…
Methods: (1) In a case-control study, 109 CHF patients, 54 were given adjunctive off-label RAN added to ACC/AHA Guideline therapy (RANCHF). MACE and SB were compared with ... adults with triggered premature ventricular…
older. With this approval and with the increasing use of TCZ off-label for other nonrheumatologic conditions such as Castleman’s Disease and its variant TAFRO syndrome, where else might
consent (11.29%). Also the service was rated low at explaining that a medicine is ‘off-label’ (4.55%). Conclusions: CAMHS focuses their work on the whole family. Consent is gained from
prescribed for the treatment of narcolepsy or even for the treatment in some instances off-label for (attention-deficit/hyperactivity disorder) ADHD or for cognitive impairment in patients with schizophrenia
variety of pigmentary lesions, the settings can be tweaked for a number of off-label uses which I routinely use in my clinical practice. The effects of a Q-switched
relationship between risk mitigation and product liability? How to handle risks in off-label uses without creating product liability nightmares? How to factor regulatory risk into the equation? Ultimately risk
especially considering that 90% of those affected with a rare disease are treated with off-label prescriptions, and less than 1% of rare diseases have an FDA approved drug. Families
level of clinical pharmacy services the analgesic therapy was improved by elimination of an off-label drug, moreover hydration regimen and prevention of chemotherapy induced nausea and vomiting was optimized
Ability of roflumilast to reduce sputum eosinophils, neutrophils, and macrophages makes it of potential off-label use in asthma. In a lipopolysaccharide-induced inflammation model in Wistar rats, "inhaled" roflumilast
prescribing (r=-0.21, n=136, p=0.014). Those who do prescribe seem to favor off-label medications and avoid Naltrexone IM formulation. Providers acknowledge that the majority of those with ... traditionally…
fusion protein inhibited VSMC proliferation significantly. In contrast, neither addition of bisphosphonates, a current off-label treatment used for GACI, nor inorganic pyrophosphate (PPi) affected proliferation of…
existent. The absence of approved medications for vascularrndementia offers practicing clinicians few treatment options. Off-label use of Alzheimer’s approved drugs and antidepressants are morernpractical than risking…
cause psychological stress, and the lack of effective therapies can cause patients to pursue off-label use of potentially hazardous treatments. Parathyroid hormone-related peptide (PTHrP) is a hair cycle
halting growth in patients with recurrent pterygium. Method and materials: The study was an off-label; 2-dosing, interventional case series involving 20 patients with recurrent pterygium. They received subconjunctival
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.